PARP1 and cardiac hypertrophy: PARP-1 activation induces cardiac hypertrophy mainly by catalyzing the transfer of ADP-ribose from nicotinamide adenine dinucleotide (NAD+) to its target protein, consuming intracellular NAD+, impairing energy metabolism, and causing decreased activity of type III histone deacetylase (SIRTs).